Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NCBP2 anticorps (AA 1-156)

NCBP2 Reactivité: Humain WB, IHC, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7161752
  • Antigène Voir toutes NCBP2 Anticorps
    NCBP2 (Nuclear Cap Binding Protein Subunit 2 (NCBP2))
    Épitope
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-156
    Reactivité
    • 33
    • 19
    • 6
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 32
    • 2
    Lapin
    Clonalité
    • 32
    • 2
    Polyclonal
    Conjugué
    • 22
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NCBP2 est non-conjugé
    Application
    • 17
    • 13
    • 13
    • 8
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
     Réactivité croisée
    Humain, Souris
    Purification
    Antigen Affinity Purified
    Immunogène
    Recombinant Human Nuclear cap-binding protein subunit 2 protein (1-156AA)
    Isotype
    IgG
    Top Product
    Discover our top product NCBP2 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:1000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    NCBP2 (Nuclear Cap Binding Protein Subunit 2 (NCBP2))
    Autre désignation
    NCBP2 (NCBP2 Produits)
    Synonymes
    anticorps CBP20, anticorps CG12357, anticorps Dmel\\CG12357, anticorps 20kDa, anticorps 5930413E18Rik, anticorps AA536802, anticorps AI843301, anticorps C79367, anticorps CHUNP6917, anticorps zgc:92592, anticorps CBC2, anticorps NIP1, anticorps ATCBP20, anticorps CAP-binding protein 20, anticorps MLN1.12, anticorps MLN1_12, anticorps Ncbp2, anticorps cap binding protein 20, anticorps nuclear cap binding protein subunit 2, anticorps nuclear cap binding protein subunit 2, 20kDa, anticorps nuclear cap binding protein subunit 2 L homeolog, anticorps nuclear cap-binding protein subunit 2, anticorps CAP-binding protein 20, anticorps Nuclear cap-binding protein subunit 2, anticorps Cbp20, anticorps Ncbp2, anticorps ncbp2, anticorps NCBP2, anticorps ncbp2.L, anticorps CBP20, anticorps ncbp-2
    Sujet

    Background: Component of the cap-binding complex (CBC), which binds co-transcriptionally to the 5\\\' cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus via its interaction with ALYREF/THOC4/ALY, leading to the recruitment of the mRNA export machinery to the 5\\\' end of mRNA and to mRNA export in a 5\\\' to 3\\\' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC) via its interaction with UPF1, promoting the interaction between UPF1 and UPF2. The CBC complex is also involved in \\\'failsafe\\\' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with SRRT/ARS2, thereby being required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of PARN, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, NCBP2/CBP20 recognizes and binds capped RNAs (m7GpppG-capped RNA) but requires NCBP1/CBP80 to stabilize the movement of its N-terminal loop and lock the CBC into a high affinity cap-binding state with the cap structure.

    Aliases: NCBP2 antibody, CBP20 antibody, PIG55 antibody, Nuclear cap-binding protein subunit 2 antibody, 20 kDa nuclear cap-binding protein antibody, Cell proliferation-inducing gene 55 protein antibody, NCBP 20 kDa subunit antibody, CBP20 antibody, NCBP-interacting protein 1 antibody, NIP1 antibody

    UniProt
    P52298
    Pathways
    Ribonucleoprotein Complex Subunit Organization, Methionine Biosynthetic Process
Vous êtes ici: